Abstract
We report on a case of reversible Pisa syndrome developed after treatment with galantamine in a patient with Alzheimer's disease without previous exposure to neuroleptic or other cholinesterase inhibitors. Complete and persistent resolution of the syndrome was achieved several weeks after botulinum toxin type-A injection.
(c) 2004 Movement Disorder Society.
MeSH terms
-
Aged
-
Alzheimer Disease / diagnosis
-
Alzheimer Disease / drug therapy*
-
Botulinum Toxins, Type A / therapeutic use
-
Cholinesterase Inhibitors / adverse effects*
-
Cholinesterase Inhibitors / therapeutic use
-
Cognition Disorders / diagnosis
-
Cognition Disorders / drug therapy
-
Dystonia / chemically induced*
-
Dystonia / drug therapy
-
Dystonia / physiopathology
-
Female
-
Galantamine / adverse effects*
-
Galantamine / therapeutic use
-
Humans
-
Neuromuscular Agents / therapeutic use
-
Neuropsychological Tests
-
Severity of Illness Index
-
Syndrome
Substances
-
Cholinesterase Inhibitors
-
Neuromuscular Agents
-
Galantamine
-
Botulinum Toxins, Type A